NPI: 1417484452 · WHEELING, WV 26003 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/22/2017
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/22/2017 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,573 | $20K |
| 2019 | 9,264 | $1.25M |
| 2020 | 6,481 | $711K |
| 2021 | 3,375 | $19K |
| 2022 | 625 | $35K |
| 2023 | 908 | $49K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 9,831 | 780 | $1.28M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,993 | 623 | $409K |
| A4657 | Syringe, with or without needle, each | 850 | 546 | $224K |
| J1756 | Injection, iron sucrose, 1 mg | 664 | 184 | $123K |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,178 | 352 | $52K |
| 83970 | 172 | 161 | $676.64 | |
| 82108 | 64 | 49 | $413.00 | |
| 82728 | 169 | 158 | $223.82 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 55 | 47 | $174.06 |
| 85041 | 443 | 423 | $149.93 | |
| 83550 | 170 | 158 | $143.62 | |
| 85048 | 455 | 435 | $126.59 | |
| 83540 | 170 | 159 | $106.46 | |
| G0008 | Administration of influenza virus vaccine | 12 | 12 | $0.07 |